1100 Architect Named to Forbes Americas Top Architects 2025 List Unveils Bold BostonArea Project GitHubs AI Coding Edge Slips Amid Outages and Rising Competition Testing Microsofts Strategy Enterprise Products Partners Receives Higher Price Target as Analysts Remain Cautious on Outlook Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand Robotic Sewing Machines Could Reshape Clothing Manufacturing and Reshore Production from Asia South Korea Deputy PM Urges Public Benefit from AI Wealth Amid Samsung Labor Strife WFRD Q1 2026 Earnings Strong EPS Beat but Stock Declines TFI International Q1 2026 Earnings EPS Beats Estimates by Over 11 Shares Edge Higher INMD Q1 2026 Earnings EPS Misses Estimates as Company Faces Headwinds IMCC Q1 2026 Earnings Negative EPS Reported Amid Limited Disclosure Shares Dip 5 Idaho Strategic Resources Inc IDR Q1 2026 Earnings EPS Misses Estimates as Stock Declines Community Healthcare Trust CHCT Q1 2026 Earnings Massive EPS Beat Masks Continued Market Caution MidCap Financial Investment 800 Notes 2028 MFICL Edge Higher in Quiet Trading Fractyl Health GUTS Slides 296 as Stock Tests Key Support Levels PermaFix Environmental Services PESI Holds Steady with Modest Gain Testing Key Support Levels Braskem BAK Slides 5 Petrochemical Gloom Weighs on ADR as Support Nears Rocket Companies RKT Dips 25 as Housing Sensitivity Weighs on Sentiment AIProof Investing The Rise of HALO Stocks and a New ETF for HumanCentric Assets CTOR Q1 2026 Earnings EPS Falls Far Below Estimates as PreRevenue Company Continues RD Investment Bakkt BKKT Faces Selling Pressure as Shares Decline 357 Amid Volatile Trading GPACU Holds Steady at 1009 as Market Awaits Business Combination News NorthWestern Energy NWE Holds Steady Near 72 as RangeBound Trading Persists Starry Sea Acquisition Corp Rights SSEAR Flat at 017 as Trading Remains Tight Innoviz Technologies INVZ Rebounds from Key Support Is a Trend Reversal Brewing TEN Holdings Inc XHLD Holds Steady Near Support Amid Low Volatility MasterBrand Inc MBC Surges Over 7 Resistance and Support in Focus Stoke Therapeutics STOK Sees Minor Decline as Shares Test Support Near 28 Level